537 related articles for article (PubMed ID: 3878875)
1. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
4. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
5. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
7. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
Ferraccioli G; Karsh J; Osterland CK
J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
11. Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immune complexes.
De Clerck LS; Gigase PL; Bridts CH; Stevens WJ
Clin Exp Immunol; 1988 Apr; 72(1):32-6. PubMed ID: 3396220
[TBL] [Abstract][Full Text] [Related]
12. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
Crawhall JC
Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
[TBL] [Abstract][Full Text] [Related]
15. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
[TBL] [Abstract][Full Text] [Related]
17. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
Wagner T; Abraham G; Baum J
J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
19. IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes.
Carson DA; Bayer AS; Eisenberg RA; Lawrance S; Theofilopoulos A
Clin Exp Immunol; 1978 Jan; 31(1):100-3. PubMed ID: 639341
[TBL] [Abstract][Full Text] [Related]
20. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
Lorber M; Samuel D; Amlot P; Panayi GS
Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]